196 related articles for article (PubMed ID: 29061728)
1. Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial.
Lobo MD; Ott C; Sobotka PA; Saxena M; Stanton A; Cockcroft JR; Sulke N; Dolan E; van der Giet M; Hoyer J; Furniss SS; Foran JP; Witkowski A; Januszewicz A; Schoors D; Tsioufis K; Rensing BJ; Scott B; Ng GA; Schmieder RE
Hypertension; 2017 Dec; 70(6):1099-1105. PubMed ID: 29061728
[TBL] [Abstract][Full Text] [Related]
2. Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension.
Ott C; Lobo MD; Sobotka PA; Mahfoud F; Stanton A; Cockcroft J; Sulke N; Dolan E; van der Giet M; Hoyer J; Furniss SS; Foran JP; Witkowski A; Januszewicz A; Schoors D; Tsioufis K; Rensing BJ; Saxena M; Scott B; Ng GA; Achenbach S; Schmieder RE
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 28003251
[TBL] [Abstract][Full Text] [Related]
3. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial.
Lobo MD; Sobotka PA; Stanton A; Cockcroft JR; Sulke N; Dolan E; van der Giet M; Hoyer J; Furniss SS; Foran JP; Witkowski A; Januszewicz A; Schoors D; Tsioufis K; Rensing BJ; Scott B; Ng GA; Ott C; Schmieder RE;
Lancet; 2015 Apr; 385(9978):1634-41. PubMed ID: 25620016
[TBL] [Abstract][Full Text] [Related]
4. Application of a central iliac arteriovenous coupler device in severe treatment-resistant hypertension: a 3.5-year follow-up.
Jung S; Ott C; Karg MV; Bosch A; Schmid M; Schlundt C; Achenbach S; Schmieder RE
J Hypertens; 2018 Dec; 36(12):2471-2477. PubMed ID: 30113527
[TBL] [Abstract][Full Text] [Related]
5. Central arteriovenous anastomosis for hypertension: it is not all about sympathomodulation.
Brier TJ; Jain AK; Lobo MD
Future Cardiol; 2015 Sep; 11(5):503-6. PubMed ID: 26403331
[TBL] [Abstract][Full Text] [Related]
6. Central arteriovenous anastomosis to treat resistant hypertension.
Kapil V; Sobotka PA; Lobo MD; Schmieder RE
Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):8-15. PubMed ID: 29084002
[TBL] [Abstract][Full Text] [Related]
7. The hemodynamic effects of a central iliac arteriovenous anastomosis at 6 months in patients with resistant and uncontrolled hypertension.
Eysenck W; van Zalen J; Freemantle N; Lloyd G; Furniss S; Sulke N
J Clin Hypertens (Greenwich); 2019 Sep; 21(9):1399-1405. PubMed ID: 31347773
[TBL] [Abstract][Full Text] [Related]
8. [Central arteriovenous anastomosis: the solution for patients with treatment-resistant hypertension?].
Spiering W; de Leeuw PW
Ned Tijdschr Geneeskd; 2015; 159():A9129. PubMed ID: 26131753
[TBL] [Abstract][Full Text] [Related]
9. The ROX coupler: creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature.
Foran JP; Jain AK; Casserly IP; Kandzari DE; Rocha-Singh KJ; Witkowski A; Katzen BT; Deaton D; Balmforth P; Sobotka PA
Catheter Cardiovasc Interv; 2015 Apr; 85(5):880-6. PubMed ID: 25345578
[TBL] [Abstract][Full Text] [Related]
10. Creation of an iliac arteriovenous shunt lowers blood pressure in chronic obstructive pulmonary disease patients with hypertension.
Faul J; Schoors D; Brouwers S; Scott B; Jerrentrup A; Galvin J; Luitjens S; Dolan E
J Vasc Surg; 2014 Apr; 59(4):1078-83. PubMed ID: 24484754
[TBL] [Abstract][Full Text] [Related]
11. The use of a novel ROX central arteriovenous fistula formation device in a patient with severe drug-resistant hypertension and prior aortic graft.
Hensey M; Smyth E; Gilroy E; Galvin J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):114-117. PubMed ID: 28471088
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
[TBL] [Abstract][Full Text] [Related]
13. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
Böhm M; Mahfoud F; Ukena C; Hoppe UC; Narkiewicz K; Negoita M; Ruilope L; Schlaich MP; Schmieder RE; Whitbourn R; Williams B; Zeymer U; Zirlik A; Mancia G;
Hypertension; 2015 Apr; 65(4):766-74. PubMed ID: 25691618
[TBL] [Abstract][Full Text] [Related]
14. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
[TBL] [Abstract][Full Text] [Related]
15. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
16. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension and paroxysmal AF.
Eysenck W; van Zalen J; Freemantle N; Lloyd G; Furniss S; Sulke N
Am Heart J; 2019 Jan; 207():86-87. PubMed ID: 30414626
[TBL] [Abstract][Full Text] [Related]
17. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Walnut Diet on Office and 24-Hour Ambulatory Blood Pressure in Elderly Individuals.
Domènech M; Serra-Mir M; Roth I; Freitas-Simoes T; Valls-Pedret C; Cofán M; López A; Sala-Vila A; Calvo C; Rajaram S; Sabaté J; Ros E
Hypertension; 2019 May; 73(5):1049-1057. PubMed ID: 30879358
[TBL] [Abstract][Full Text] [Related]
19. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
[TBL] [Abstract][Full Text] [Related]
20. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
